JCollBiomed focuses on advancing collaborative, interdisciplinary, and translational research across the biomedical sciences. The journal provides a scholarly platform for studies investigating the biological mechanisms underlying health and disease, as well as research that translates fundamental scientific findings into innovations in disease prevention, diagnosis, treatment, and health improvement.

The journal welcomes original, high-quality scholarly works covering, but not limited to, the following areas:

• Molecular and cellular biology;
• Biochemistry and molecular medicine;
• Anatomy, histology, physiology, and pathology;
• Immunology and inflammation;
• Medical microbiology, parasitology, and infectious diseases;
• Genetics, genomics, epigenetics, proteomics, metabolomics, and bioinformatics;
• Pharmacology, toxicology, drug discovery, and natural product research;
• Cancer biology and molecular oncology;
• Cardiovascular, metabolic, neurological, reproductive, and degenerative diseases;
• Biomarkers, molecular diagnostics, and precision medicine;
• Biomedical imaging and radiological sciences;
• Regenerative medicine, stem cell research, tissue engineering, and nanomedicine;
• Biomedical technology and laboratory-based methodological innovations;
• Translational, clinical, and population-based research with clear biomedical relevance; and
• Interdisciplinary and multicentre research addressing contemporary health challenges and contributing to the achievement of Sustainable Development Goal 3 (SDG 3).

JCollBiomed accepts original research articles, systematic reviews, meta-analyses, scoping reviews, critical narrative reviews, brief research reports, methodological papers, and other scholarly contributions relevant to biomedical science. All manuscripts should demonstrate scientific novelty, methodological rigour, ethical compliance, and a clear contribution to advancing the understanding of human health or improving health outcomes.